U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07444372) titled 'Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation' on Feb. 25.
Brief Summary: Atrial fibrillation (AF) is one of the most common clinical arrhythmias. Catheter ablation is an effective therapeutic strategy; however, recurrence rates remain substantial, ranging from 20% to 45%. Previous studies have established a strong association between obstructive sleep apnea (OSA) and the risk of AF recurrence following ablation. While continuous positive airway pressure (CPAP) is the standard intervention for OSA, and some observational studies suggest it may reduce post-ablation recurrence in patients wi...